Nitric oxide protects the ultrastructure of pancreatic acinar cells in the course of caerulein-induced acute pancreatitis

被引:18
作者
Andrzejewska, A
Jurkowska, G
机构
[1] Med Acad Bialystok, Dept Pathomorphol, PL-15269 Bialystok, Poland
[2] Med Acad Bialystok, Dept Gastroenterol, PL-15269 Bialystok, Poland
关键词
acute pancreatitis; nitric oxide; ultrastructure;
D O I
10.1046/j.1365-2613.1999.00126.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nitric oxide (NO) as a unique biologicalmediator that has been implicated in many physiological and pathophysiological processes may have a significant influence on the course of acute pancreatitis and the recovery process. The aim of the study was to evaluate the effect of a NO synthase inhibitor or a substrate for NO endogenous production on the ultrastructural features of the acinar cells in the course of caerulein-induced acute pancreatitis. Acute pancreatitis was induced in the rats by a supramaximal dose of caerulein, During acute pancreatitis induction, the rats were treated with L-arginine (the substrate for NO synthesis), N-G-nitro-L-arginine (L-NNA, NO synthase inhibitor), L-arginine + L-NNA or saline. Light and electron microscopy examinations were performed in all groups after pancreatitis induction and additionally after 7 and 14 days of recovery. The study demonstrated that the NO synthase inhibitor given during pancreatitis induction in rats enhances the damage to the acinar cells, detected ultrastructurally, and increases the cellular inflammatory infiltration. In the later period, the considerable damage to the mitochondria and the changes in secretory compartment were observed, including dilated cisternae of Golgi apparatus, focal degranulation of rough endoplasmic reticulum, and reduced number of zymogen granules and condensing vacuoles. L-arginine reversed to some extent the deleterious effect of L-NNA, although when administered alone it had no apparent effect on the ultrastructure of pancreatic acinar cells compared with untreated animals. The obtained results indicate that the NO synthase inhibitor enhances the ultrastructural degenerative alterations in the pancreatic acinar cells in the course of caerulein-induced acute pancreatitis and confirm the protective role of endogenous nitric oxide in this disease.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 33 条
[1]   NITRIC-OXIDE MODULATES PANCREATIC EDEMA FORMATION IN RAT CERULEIN-INDUCED PANCREATITIS [J].
ABE, T ;
SHIMOSEGAWA, T ;
SATOH, A ;
ABE, R ;
KIKUCHI, Y ;
KOIZUMI, M ;
TOYOTA, T .
JOURNAL OF GASTROENTEROLOGY, 1995, 30 (05) :636-642
[2]   NITRIC-OXIDE - MEDIATOR, MURDERER, AND MEDICINE [J].
ANGGARD, E .
LANCET, 1994, 343 (8907) :1199-1206
[3]   IMMUNOCYTOCHEMICAL EVIDENCE FOR A MITOCHONDRIALLY LOCATED NITRIC-OXIDE SYNTHASE IN BRAIN AND LIVER [J].
BATES, TE ;
LOESCH, A ;
BURNSTOCK, G ;
CLARK, JB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 213 (03) :896-900
[4]   Resolving the nitric oxide paradox in acute tissue damage [J].
Billiar, TR ;
Harbrecht, BG .
GASTROENTEROLOGY, 1997, 113 (04) :1405-1407
[5]   NITRIC-OXIDE - NOVEL BIOLOGY WITH CLINICAL RELEVANCE [J].
BILLIAR, TR .
ANNALS OF SURGERY, 1995, 221 (04) :339-349
[6]   NITRIC-OXIDE SYNTHASE INHIBITION AND PLATELET-FUNCTION [J].
BODZENTALUKASZYK, A ;
GABRYELEWICZ, A ;
LUKASZYK, A ;
BIELAWIEC, M ;
KONTUREK, JW ;
DOMSCHKE, W .
THROMBOSIS RESEARCH, 1994, 75 (06) :667-672
[7]   Transcellular regulation of cell respiration by nitric oxide generated by activated macrophages [J].
Brown, GC ;
Foxwell, N ;
Moncada, S .
FEBS LETTERS, 1998, 439 (03) :321-324
[8]   Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: Implications for inflammatory, neurodegenerative and ischaemic pathologies [J].
Brown, GC .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 174 (1-2) :189-192
[9]   NITRIC-OXIDE REGULATES MITOCHONDRIAL RESPIRATION AND CELL FUNCTIONS BY INHIBITING CYTOCHROME-OXIDASE [J].
BROWN, GC .
FEBS LETTERS, 1995, 369 (2-3) :136-139
[10]   Microcirculatory disturbances of the pancreas in cerulein-induced acute pancreatitis in rats with reference to L-arginine, heparin, and procaine treatment [J].
Dobosz, M ;
Hac, S ;
Mionskowska, L ;
Dobrowolski, S ;
Wajda, Z .
PHARMACOLOGICAL RESEARCH, 1997, 36 (02) :123-128